Ming Wang
25Patents
5h-index
130Co-inventors
68Inventor score
Filing activity: Mar 11, 1999 → Dec 12, 2016
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6911443B2 | Imidazopyrimidine derivatives and triazolopyrimidine derivatives | Human Necessities | 28 | Expired |
| US7517880B2 | Inhibition of p38 kinase using symmetrical and unsymmetrical diphenyl ureas | Emerging Cross-Sectional Technologies | 18 | Expired |
| US6455516B1 | Method and compounds for use in the treatment of steroid induced states of the central nervous system | Human Necessities | 18 | Expired |
| US6660752B2 | 2,6-Substituted chroman derivatives useful as beta-3 adrenoreceptor agonists | Chemistry; Metallurgy | 12 | Expired |
| US6828335B2 | Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation | Emerging Cross-Sectional Technologies | 6 | Expired |
| US8114860B2 | GABA-steroid antagonists and their use for the treatment of CNS disorders | Human Necessities | 4 | Active |
| US7582645B2 | Pyrimidine derivatives for treatment of hyperproliferative disorders | Chemistry; Metallurgy | 3 | Expired |
| US8119619B2 | Pregnane steroids and their use in the treatment of CNS disorders | Human Necessities | 3 | Active |
| US7112597B2 | Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation | Emerging Cross-Sectional Technologies | 3 | Expired |
| US10450335B2 | Antiviral oxime phosphoramide compounds | Human Necessities | 3 | Active |
| US7678804B2 | Pyrimidine derivatives for treatment of hyperproliferative disorders | Chemistry; Metallurgy | 3 | Active |
| US9751881B2 | Inhibitors of the renal outer medullary potassium channel | Chemistry; Metallurgy | 2 | Active |
| US7358386B2 | Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation | Emerging Cross-Sectional Technologies | 2 | Expired |
| US9499534B2 | Thiazole-substituted aminopyrimidines as spleen tyrosine kinase inhibitors | Chemistry; Metallurgy | 1 | Active |
| US6919371B2 | 2,6-substituted chroman derivatives useful as beta-3 adrenoreceptor agonists | Chemistry; Metallurgy | 1 | Expired |
| US10472344B2 | Factor XIa inhibitors | Chemistry; Metallurgy | 0 | Active |
| US10065945B2 | Isoquinoline derivatives as MGAT2 inhibitors | Chemistry; Metallurgy | 0 | Active |
| US7888340B2 | Pregnane steroids and their use in the treatment of CNS disorders | General | 0 | Revoked |
| US8372824B2 | GABA-steroid antagonists and their use for the treatment of CNS disorders | Human Necessities | 0 | Active |
| US9815796B2 | Pyrimidone carboxamide compounds as PDE2 inhibitors | Chemistry; Metallurgy | 0 | Active |
| US7960367B2 | Pregnane steroids and their use in the treatment of CNS disorders | Human Necessities | 0 | Expired |
| US8552203B2 | Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation | Chemistry; Metallurgy | 0 | Active |
| US7582646B2 | Pyrimidine derivatives for treatment of hyperproliferative disorders | General | 0 | Revoked |
| US10357481B2 | Substituted triazolo bicyclic compounds as PDE2 inhibitors | Chemistry; Metallurgy | 0 | Active |
| US8541618B2 | Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.